Management

Anders has been involved in business development, sales, and corporate management in various roles since 2005. In January 2017, he became CEO of Sensec Personal Safety and successfully led the company to profitability before it was acquired by MediRätt and later renamed iZafe. Prior to that, Anders served as Business Area Manager for the same company and previously as Sales Manager at the broadband operator Net1. Anders holds a degree in Business Management from IHM Business School.

Anders’ direct and indirect holdings: 1,598,773 class B shares. 600,000 subscription options TO11. Warrants in LTIP2023: 1,116,407 series A, 1,116,407 series B, 558,203 series C

Marius holds a Master of Science in Business and Economics from Linköping University and has also completed a semester at the University of Mannheim, focusing on finance. He has experience in accounting and corporate governance within the finance and retail sectors. Before assuming his current position, Marius played a prominent role as Head of Finance at Urbanista AB, where he was instrumental in optimizing and managing data and financial analyses.

Marius’ direct and potential indirect holdings: 177,983 Class B shares. Subscription options in LTIP2023: 198,204 of Series A, 198,204 of Series B, 99,102 of Series C.

Erik holds a Master’s degree in Medical Engineering from Lund University. He has previous experience in product development in the healthcare industry, leading product teams and specializing in e-health services. Erik most recently worked at the consulting firm C.A.G, focusing on the development of e-health services.

Erik’s direct and indirect holdings: 258,327 class B shares. 300,000 subscription options TO11. Warrants in LTIP2023: 558,204 series A, 558,204 series B, 279,102 series C

Helena has held various leadership positions in the business sector. Most recently, she served as Secretary-General of the Beat Diabetes Foundation, where she led the Nordic foundation since January 2019, aiming to increase diabetes awareness and bring together the entire diabetes ecosystem. With over 12 years of broad experience in partnerships, project management, and sales, gained from companies such as Stockholmsmässan, Bonnier Group, Viaplay Group, and Vattenfall AB, Helena plays a crucial role in driving strategic initiatives and optimizing efficiency for our partners.

Helena’s direct and indirect holdings: 138,744 class B shares. Warrants in LTIP2023: 558,204 series A, 558,204 series B, 279,102 series C

Richard Wolff is a lawyer specialized in intellectual property rights, commercialization strategies, and business law. He has extensive experience as a corporate lawyer and consultant, as well as in business development and the start-up and scale-up world. He has worked at patent firms, law firms, served as Director Legal at Tele2 IoT AB, Vice-President at Wyless Plc, Vice-President and Operations Manager at Valea AB, and Chief Legal Officer at Cambio Healthcare Systems AB (current).

Independent of major shareholders and the Company or management. Richard’s direct and indirect holdings: 37,500 class B shares. 500,000 subscription options TO12B.

Anna has extensive and broad experience from the public sector, including roles as City Director, CFO, and interim executive in several large organizations. She has also served on the boards of pension funds and other organizations, combining operational and strategic responsibilities. Before joining the Board of iZafe, she was Acting Chief Financial Officer for the City of Solna. Anna holds a degree in Accounting from Southern Illinois University, Carbondale, and has completed board training at the Swedish Academy of Board Directors.

Independent in relation to major shareholders and the Company or its management. Anna’s direct and indirect holdings: 0 class B shares.

Has extensive experience in brand development and communication with a focus on e-health and the public sector. Has been Chief Marketing & Communication Officer at Cambio Healthcare Systems AB since 2017. Previously, Strategic Marketing Manager for the public sector at CGI Sweden (2011-2017).

Independent of major shareholders and the Company or management. Jenny’s direct and indirect holdings: 0 class B shares.

Samuel has long-standing experience in communication, political advocacy, and public affairs, particularly within the healthcare sector. He has held both strategic and operational roles, advising the Swedish government as well as holding senior positions in the private sector. In addition to his board position at iZafe, Samuel is Head of Communications at Unilabs. He has previously served as Head of Communications at Kry and as a senior advisor at JKL and Hallvarsson & Halvarsson. Samuel holds a bachelor’s degree in Economics and Political Science from Uppsala University and has also studied at the University of Michigan.

Independent in relation to major shareholders and the Company or its management. Samuel’s direct and indirect holdings: 0 class B shares.

Göran is a specialist in general medicine, inventor of the Dosell medication robot, and co-founder of iZafe Group AB (formerly MediRätt AB), where he also served as CEO from 2008 to 2012. Currently, Göran works part-time as a general practitioner. He is the inventor of several patents, including iZafe’s medication robot, Dosell. Previously, Göran served as Chairman of the Swedish Association of General Practitioners and the World Organization of Family Doctors (WONCA). He is also the founder of neighborhood emergency care clinics.

Göran’s direct and indirect holdings: 325,000 class A shares and 2,151,847 class B shares.